| 27.02 12:49 | dpa-AFX: Henry Schein Q4 Profit Misses Estimates, Sees Higher FY24 Results; Stock Down In Pre-market |
| 27.02 12:46 | dpa-AFX: *HENRY SCHEIN EXPECT FY24 SALES GROWTH OF APPROX. 8% TO 12% |
| 27.02 12:46 | dpa-AFX: *HENRY SCHEIN EXPECTS FY24 NON-GAAP EPS OF $5.00 TO $5.16 |
| 27.02 12:46 | dpa-AFX: *HENRY SCHEIN Q4 ADJ. EBITDA $172 MLN VS $279 MLN LAST YEAR |
| 27.02 12:46 | dpa-AFX: *HENRY SCHEIN Q4 NET SALES $3.17 BLN VS. $3.71 BLN LAST YEAR |
| 27.02 12:46 | dpa-AFX: *HENRY SCHEIN Q4 OPERATING INCOME $39 MLN VS. $72 MLN LAST YEAR |
| 27.02 12:44 | dpa-AFX: *HENRY SCHEIN Q4 NET INCOME $18 MLN VS. $47 MLN LAST YEAR |
| 27.02 12:43 | dpa-AFX: *HENRY SCHEIN Q4 NET INCOME $18 MLN VS. $47 MLN LAST YEAR |
| 27.02 12:38 | dpa-AFX: Henry Schein Inc. Q4 Profit Decreases, misses estimates |
| 27.02 12:36 | dpa-AFX: *HENRY SCHEIN Q4 GAAP EPS $0.13 AND NON-GAAP EPS $0.66 |
| 20.12 13:55 | dpa-AFX: Henry Schein To Acquire TriMed To Enter Orthopedic Extremities Specialty Segment |
| 20.12 13:08 | dpa-AFX: *HENRY SCHEIN TO ENTER EXTREMITY SPECIALTY SEGMENT OF ORTHOPEDIC MARKET; AGREES TO BUY MAJORITY INTEREST IN TRIMED |
| 12.12 07:57 | dpa-AFX: *JPMORGAN RAISES HENRY SCHEIN TO 'OVERWEIGHT' (NEUTRAL) - PRICE TARGET 82 (71) USD |
| 12.12 07:57 | dpa-AFX: *JPMORGAN HEBT HENRY SCHEIN AUF 'OVERWEIGHT' (NEUTRAL) - ZIEL 82 (71) USD |
| 04.12 08:16 | dpa-AFX: Henry Schein: Zahn Dental To Distribute Myerson's Trusana Premium Denture System |
| 04.12 08:07 | dpa-AFX: *HENRY SCHEIN'S ZAHN DENTAL TO EXCLUSIVELY DISTRIBUTE MYERSON'S TRUSANA PREMIUM DENTURE SYSTEM |
| 13.11 15:34 | dpa-AFX: *HENRY SCHEIN +1,8% NACH QUARTALSZAHLEN UND AUSBLICK |
| 13.11 15:00 | dpa-AFX: Henry Schein Q3 23 Earnings Conference Call AT 10:00 AM ET |
| 13.11 13:13 | dpa-AFX: *HENRY SCHEIN VORBÖRSLICH -3,5% NACH QUARTALSZAHLEN UND VERDÜSTERTEM AUSBLICK |
| 13.11 13:00 | dpa-AFX: Henry Schein Updates 2023 Guidance; Sales To Decline Primarily Due To Cybersecurity Incident |
|
|
